Jordan JT - Search Results

1

Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial.

Frigault MJ, Dietrich J, Gallagher K, Roschewski M, Jordan JT, Forst D, Plotkin SR, Cook D, Casey KS, Lindell KA, Depinho GD, Katsis K, Elder EL, Leick MB, Choi B, Horick N, Preffer F, Saylor M, McAfee S, O'Donnell PV, Spitzer TR, Dey B, DeFilipp Z, El-Jawahri A, Batchelor TT, Maus MV, Chen YB. Frigault MJ, et al. Among authors: jordan jt. Blood. 2022 Apr 14;139(15):2306-2315. doi: 10.1182/blood.2021014738. Blood. 2022. PMID: 35167655 Free PMC article. Clinical Trial.

2

Teaching NeuroImages: brain mass with hilar adenopathy: the importance of histologic diagnosis.

Jordan JT, Yang HS, Narendra D, Plotkin SR. Jordan JT, et al. Neurology. 2014 May 6;82(18):e161-2. doi: 10.1212/WNL.0000000000000393. Neurology. 2014. PMID: 24799521

3

Magnetic resonance imaging observations in primary central nervous system lymphoma.

Jordan JT, Plotkin S, Dietrich J. Jordan JT, et al. JAMA Neurol. 2014 Jul 1;71(7):918-9. doi: 10.1001/jamaneurol.2014.70. JAMA Neurol. 2014. PMID: 24861724 No abstract available.

4

A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.

Beauchamp RL, James MF, DeSouza PA, Wagh V, Zhao WN, Jordan JT, Stemmer-Rachamimov A, Plotkin SR, Gusella JF, Haggarty SJ, Ramesh V. Beauchamp RL, et al. Among authors: jordan jt. Oncotarget. 2015 Jul 10;6(19):16981-97. doi: 10.18632/oncotarget.4858. Oncotarget. 2015. PMID: 26219339 Free PMC article.

5

Glioblastoma care in the elderly.

Jordan JT, Gerstner ER, Batchelor TT, Cahill DP, Plotkin SR. Jordan JT, et al. Cancer. 2016 Jan 15;122(2):189-97. doi: 10.1002/cncr.29742. Epub 2015 Nov 30. Cancer. 2016. PMID: 26618888 Free article. Review.

6

Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1: Population-Based Approach.

Terry AR, Jordan JT, Schwamm L, Plotkin SR. Terry AR, et al. Among authors: jordan jt. Stroke. 2016 Jan;47(1):60-5. doi: 10.1161/STROKEAHA.115.011406. Epub 2015 Dec 8. Stroke. 2016. PMID: 26645253

7

First use of patient reported outcomes measurement information system (PROMIS) measures in adults with neurofibromatosis.

Talaei-Khoei M, Riklin E, Merker VL, Sheridan MR, Jordan JT, Plotkin SR, Vranceanu AM. Talaei-Khoei M, et al. Among authors: jordan jt. J Neurooncol. 2017 Jan;131(2):413-419. doi: 10.1007/s11060-016-2314-7. Epub 2016 Nov 29. J Neurooncol. 2017. PMID: 27900643

8

First report of factors associated with satisfaction in patients with neurofibromatosis.

Riklin E, Talaei-Khoei M, Merker VL, Sheridan MR, Jordan JT, Plotkin SR, Vranceanu AM. Riklin E, et al. Among authors: jordan jt. Am J Med Genet A. 2017 Mar;173(3):671-677. doi: 10.1002/ajmg.a.38079. Am J Med Genet A. 2017. PMID: 28211981

9

Hospice utilization in patients with malignant gliomas.

Forst D, Adams E, Nipp R, Martin A, El-Jawahri A, Aizer A, Jordan JT. Forst D, et al. Among authors: jordan jt. Neuro Oncol. 2018 Mar 27;20(4):538-545. doi: 10.1093/neuonc/nox196. Neuro Oncol. 2018. PMID: 29045712 Free PMC article.

10

Health literacy assessment in adults with neurofibromatosis: electronic and short-form measurement using FCCHL and Health LiTT.

Merker VL, McDannold S, Riklin E, Talaei-Khoei M, Sheridan MR, Jordan JT, Plotkin SR, Vranceanu AM. Merker VL, et al. Among authors: jordan jt. J Neurooncol. 2018 Jan;136(2):335-342. doi: 10.1007/s11060-017-2657-8. Epub 2017 Nov 8. J Neurooncol. 2018. PMID: 29119424

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

129 results

Search Page